Xylo Stock (NASDAQ:XYLO)

Operating from its Tel Aviv-Yafo, Israel headquarters since its establishment in 1999, Xylo Technologies Ltd. is a technology company with a broad international presence, serving markets in the United States, Europe, Asia, and Israel. The company's diverse operations are categorized into Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Other segments. In the medical field, Xylo Technologies develops and supplies devices such as the Medigus Ultrasonic Surgical Endostapler, an endoscopy system specifically designed for treating gastroesophageal reflux disease, alongside biological gels engineered to defend against biological hazards and minimize the entry of allergens and viruses through the upper airways and eyes. Beyond healthcare, its ventures extend to providing a digital advertising platform, managing online retail stores that sell various consumer items on the Amazon marketplace, and running an online platform for event organization and ticket sales. Furthermore, Xylo Technologies is involved in pioneering wireless electric vehicle charging solutions and advanced modular electronic vehicle designs. The company, previously known as Medigus Ltd., adopted its current name in April 2024.